2969 related articles for article (PubMed ID: 23665184)
21. Activation of LKB1-Akt pathway independent of phosphoinositide 3-kinase plays a critical role in the proliferation of hepatocellular carcinoma from nonalcoholic steatohepatitis.
Martínez-López N; Varela-Rey M; Fernández-Ramos D; Woodhoo A; Vázquez-Chantada M; Embade N; Espinosa-Hevia L; Bustamante FJ; Parada LA; Rodriguez MS; Lu SC; Mato JM; Martínez-Chantar ML
Hepatology; 2010 Nov; 52(5):1621-31. PubMed ID: 20815019
[TBL] [Abstract][Full Text] [Related]
22. S-adenosylmethionine regulates dual-specificity mitogen-activated protein kinase phosphatase expression in mouse and human hepatocytes.
Tomasi ML; Ramani K; Lopitz-Otsoa F; Rodríguez MS; Li TW; Ko K; Yang H; Bardag-Gorce F; Iglesias-Ara A; Feo F; Pascale MR; Mato JM; Lu SC
Hepatology; 2010 Jun; 51(6):2152-61. PubMed ID: 20196119
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.
Liu T; Yang H; Fan W; Tu J; Li TWH; Wang J; Shen H; Yang J; Xiong T; Steggerda J; Liu Z; Noureddin M; Maldonado SS; Annamalai A; Seki E; Mato JM; Lu SC
Gastroenterology; 2018 Aug; 155(2):557-571.e14. PubMed ID: 29733835
[TBL] [Abstract][Full Text] [Related]
24. Induction of human methionine adenosyltransferase 2A expression by tumor necrosis factor alpha. Role of NF-kappa B and AP-1.
Yang H; Sadda MR; Yu V; Zeng Y; Lee TD; Ou X; Chen L; Lu SC
J Biol Chem; 2003 Dec; 278(51):50887-96. PubMed ID: 14530285
[TBL] [Abstract][Full Text] [Related]
25. Involvement of CCAAT/enhancer binding protein-beta (C/EBPbeta) in epigenetic regulation of mouse methionine adenosyltransferase 1A gene expression.
Ikeda R; Nishida T; Watanabe F; Shimizu-Saito K; Asahina K; Horikawa S; Teraoka H
Int J Biochem Cell Biol; 2008; 40(9):1956-69. PubMed ID: 18346930
[TBL] [Abstract][Full Text] [Related]
26. Diminished S-adenosylmethionine biosynthesis and its metabolism in a model of hepatocellular carcinoma is recuperated by an adenosine derivative.
Lozano-Rosas MG; Chávez E; Velasco-Loyden G; Domínguez-López M; Martínez-Pérez L; Chagoya De Sánchez V
Cancer Biol Ther; 2020; 21(1):81-94. PubMed ID: 31552788
[TBL] [Abstract][Full Text] [Related]
27. Hepatoma cells from mice deficient in glycine N-methyltransferase have increased RAS signaling and activation of liver kinase B1.
Martínez-López N; García-Rodríguez JL; Varela-Rey M; Gutiérrez V; Fernández-Ramos D; Beraza N; Aransay AM; Schlangen K; Lozano JJ; Aspichueta P; Luka Z; Wagner C; Evert M; Calvisi DF; Lu SC; Mato JM; Martínez-Chantar ML
Gastroenterology; 2012 Sep; 143(3):787-798.e13. PubMed ID: 22687285
[TBL] [Abstract][Full Text] [Related]
28. Changes in methionine adenosyltransferase during liver regeneration in the rat.
Huang ZZ; Mao Z; Cai J; Lu SC
Am J Physiol; 1998 Jul; 275(1):G14-21. PubMed ID: 9655679
[TBL] [Abstract][Full Text] [Related]
29. Role of methionine adenosyltransferase 2A and S-adenosylmethionine in mitogen-induced growth of human colon cancer cells.
Chen H; Xia M; Lin M; Yang H; Kuhlenkamp J; Li T; Sodir NM; Chen YH; Josef-Lenz H; Laird PW; Clarke S; Mato JM; Lu SC
Gastroenterology; 2007 Jul; 133(1):207-18. PubMed ID: 17631143
[TBL] [Abstract][Full Text] [Related]
30. Chemopreventive N-(4-hydroxyphenyl)retinamide (fenretinide) targets deregulated NF-{kappa}B and Mat1A genes in the early stages of rat liver carcinogenesis.
Simile MM; Pagnan G; Pastorino F; Brignole C; De Miglio MR; Muroni MR; Asara G; Frau M; Seddaiu MA; Calvisi DF; Feo F; Ponzoni M; Pascale RM
Carcinogenesis; 2005 Feb; 26(2):417-27. PubMed ID: 15498786
[TBL] [Abstract][Full Text] [Related]
31. MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patients.
Gastroenterology; ; . PubMed ID: 23933603
[TBL] [Abstract][Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
